▶ 調査レポート

皮膚科診断装置および治療薬の世界市場分析・規模・シェア・成長・動向・予測:診断装置別(皮膚科診断装置、マイクロスコープ・トリコスコープ(毛髪用高解像度マイクロスコープ)、画像装置)、薬剤クラス別(抗菌剤、抗真菌剤、抗ウイルス剤、コルチコステロイド、レチノイド、免疫抑制剤、生物製剤)

• 英文タイトル:Dermatology Diagnostic Devices and Therapeutics Market (Diagnostic Devices - Dermatoscopes (Contact Oil Immersion Dermatoscopes, Cross-polarized Dermatoscopes, and Hybrid Dermatoscopes), Microscopes and Trichoscopes (Multispectral Photoacaustic Microscopy (PAM), Reflectance Confocal Microscopy (RCM), and Raman Spectroscopy), and Imaging Equipment (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, and Optical Coherence Tomography (OCT)); Drug Class - Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Transparency Market Researchが調査・発行した産業分析レポートです。皮膚科診断装置および治療薬の世界市場分析・規模・シェア・成長・動向・予測:診断装置別(皮膚科診断装置、マイクロスコープ・トリコスコープ(毛髪用高解像度マイクロスコープ)、画像装置)、薬剤クラス別(抗菌剤、抗真菌剤、抗ウイルス剤、コルチコステロイド、レチノイド、免疫抑制剤、生物製剤) / Dermatology Diagnostic Devices and Therapeutics Market (Diagnostic Devices - Dermatoscopes (Contact Oil Immersion Dermatoscopes, Cross-polarized Dermatoscopes, and Hybrid Dermatoscopes), Microscopes and Trichoscopes (Multispectral Photoacaustic Microscopy (PAM), Reflectance Confocal Microscopy (RCM), and Raman Spectroscopy), and Imaging Equipment (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, and Optical Coherence Tomography (OCT)); Drug Class - Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024 / TPM-B05100資料のイメージです。• レポートコード:TPM-B05100
• 出版社/出版日:Transparency Market Research / 2018年4月3日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Global Site License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、皮膚科診断装置および治療薬の世界市場について調べ、皮膚科診断装置および治療薬の世界規模、市場動向、市場環境、診断装置別(皮膚科診断装置、マイクロスコープ・トリコスコープ(毛髪用高解像度マイクロスコープ)、画像装置)分析、薬剤クラス別(抗菌剤、抗真菌剤、抗ウイルス剤、コルチコステロイド、レチノイド、免疫抑制剤、生物製剤)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・皮膚科診断装置および治療薬の世界市場動向
・皮膚科診断装置および治療薬の世界市場環境
・皮膚科診断装置および治療薬の世界市場規模
・皮膚科診断装置および治療薬の世界市場規模:診断装置別(皮膚科診断装置、マイクロスコープ・トリコスコープ(毛髪用高解像度マイクロスコープ)、画像装置)
・皮膚科診断装置および治療薬の世界市場規模:薬剤クラス別(抗菌剤、抗真菌剤、抗ウイルス剤、コルチコステロイド、レチノイド、免疫抑制剤、生物製剤)
・皮膚科診断装置および治療薬の世界市場:地域別市場規模・分析
・皮膚科診断装置および治療薬の北米市場規模・予測
・皮膚科診断装置および治療薬のアメリカ市場規模・予測
・皮膚科診断装置および治療薬の中南米市場規模・予測
・皮膚科診断装置および治療薬のヨーロッパ市場規模・予測
・皮膚科診断装置および治療薬のアジア市場規模・予測
・皮膚科診断装置および治療薬の中東市場規模・予測
・皮膚科診断装置および治療薬のアフリカ市場規模・予測
・競争状況・関連企業情報

Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology

This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global dermatology diagnostic devices and therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global dermatology diagnostic devices and therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types of diagnostic devices and therapeutics. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of acute skin conditions, chronic skin conditions, skin infections and other dermatology diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Dermatology Diagnostic Devices and Therapeutics Market: Segmentation

Based on product type, the global dermatology diagnostic devices market has been segmented dermatoscopes, microscopes & trichoscopes, and imaging equipment. These segments are further categorized into sub-segments such as contact oil immersion devices, cross-polarized devices and hybrid devices in dermatoscope segment; multispectral confocal microscope, reflectance confocal microscope, Raman spectroscope, and others in dermatology microscopes and trichoscopes segment; and imaging equipment are sub-segmented into x-ray, magnetic resonance imaging, ultrasound, optical coherence tomography, and others.

Based on the drug class, global dermatology therapeutics market is sub-segmented into antibacterial agents, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppressant, and biologics.

Geographically, the global dermatology diagnostic devices and therapeutics market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, Japan, India, Australia, Brazil, Egypt, Kuwait, Saudi Arabia, and UAE.

Dermatology Diagnostic Devices and Therapeutics Market: Vendor Analysis

The report also profiles major players in the dermatology diagnostic devices and therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc., LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Valeant Pharmaceuticals International, Inc., Canfield Scientific, Inc.

Global Dermatology Diagnostic Devices Market, by Product Type

Dermatoscopes
Contact Oil Immersion Dermatoscope
Cross-Polarized Dermatoscopes
Hybrid Dermatoscope
Microscopes and Trichoscopes
Multispectral Photoacaustic Microscopy (PAM)
Reflectance Confocal Microscopy (RCM)
Raman Spectroscopy
Others
Imaging Equipment
X-ray
Magnetic Resonance Imaging (MRI)
Ultrasound
Optical Coherence Tomography (OCT)
Others
Global Dermatology Therapeutics Market, by Drug Class

Antibacterial Agents
Antifungal Agents
Antiviral Agents
Corticosteroids
Retinoids
Immunosuppressants
Biologics
Global Dermatology Diagnostic Devices and Therapeutics Market, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin America
Middle East & North Africa
Egypt
Kuwait
Saudi Arabia
UAE
Rest of Middle East & North Africa
Rest of the World (RoW)

レポート目次

Section – 1 Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. Research Methodology : Assumptions

Section – 2 Executive Summary: Global Dermatology Diagnostic Devices and Therapeutics Market
2.1. Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2014–2024 (US$ Mn)
2.2. Global Dermatology Diagnostic Devices Market, by Product, 2015 (US$ Mn)
2.3. Global Dermatology Therapeutics Market, by Drug Class, 2015 (US$ Mn)
2.4. Global Market Share by Geography (Diagnostic Devices), 2015 and 2024 (Value %)
2.5. Global Market Share by Geography (Therapeutics), 2015 and 2024 (Value %)
2.6. Dermatology Diagnostic Devices Market Snapshot
2.7. Dermatology Therapeutics Market Snapshot

Section-3 Market Overview: Global Dermatology Diagnostic Devices and Therapeutics Market
3.1. Introduction and Market Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter’s five forces analysis
3.4. Company Market Share
3.4.1. Company Market Share : Dermatology Diagnostic Devices Market (2015)
3.4.2. Company Market Share : Dermatology Therapeutics Market (2015)
3.5. Market Attractiveness Analysis
3.5.1. Market Attractiveness Analysis : Dermatology Diagnostic Devices Market
3.5.2. Market Attractiveness Analysis : Dermatology Therapeutics Market
3.5.3. Market Attractiveness Analysis : By Geography
3.6. Overview of Skin Diseases

Section-4 Global Dermatology Diagnostic Devices Market Segmentation, By Product
4.1. Introduction
4.2. Global Dermatology Diagnostic Devices Market, by Product, 2014–2024 (US$ Mn)
4.3. Global Dermatoscope Market Revenue 2014–2024 (US$ Mn)
4.3.1. Global Dermatoscope Market Revenue, By Product 2014–2024 (US$ Mn)
4.4. Global Dermatology Microscopes and Trichoscopes Market Revenue 2014–2024 (US$ Mn)
4.4.1. Global Dermatology Microscopes and Trichoscopes Market Revenue, By Product 2014–2024 (US$ Mn)
4.5. Global Dermatology Imaging Equipment Market Revenue 2014–2024 (US$ Mn)
4.5.1. Global Dermatology Imaging Equipment Market Revenue, By Product 2014–2024 (US$ Mn)

Section-5 Global Dermatology Therapeutics Market Segmentation, By Drug Class
5.1. Introduction
5.2. Global Dermatology Therapeutics Market, by Drug Class, 2014–2024 (US$ Mn)
5.2.1. Global Antibacterials for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.2. Global Antifungal Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.3. Global Antiviral Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.4. Global Corticosteroids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.5. Global Retinoids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.6. Global Immunosuppresants for Dermatology Market Revenue, 2014–2024 (US$ Mn)
5.2.7. Global Biologics for Dermatology Market Revenue, 2014–2024 (US$ Mn)

Section-6 Market Segmentation – By Pipeline Assessment
6.1. Global Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3
6.2. Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)

Section-7 Global Dermatology Diagnostic Devices and Therapeutics Market Segmentation, By Region
7.1. Overview
7.1.1. Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2014–2024 (US$ Mn)
7.1.2. Global Dermatology Therapeutics Market Revenue, by Geography, 2014–2024 (US$ Mn)
7.2. North America Dermatology Diagnostic Devices and Therapeutics Market
7.2.1. North America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
7.2.2. North America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
7.2.2.1. North America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
7.2.2.2. North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
7.2.2.3. North America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
7.2.3. North America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
7.2.4. North America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.3. Europe Dermatology Diagnostic Devices and Therapeutics Market
7.3.1. Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
7.3.2. Europe Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
7.3.2.1. Europe Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
7.3.2.2. Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
7.3.2.3. Europe Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
7.3.3. Europe Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
7.3.4. Europe Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.4. Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market
7.4.1. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
7.4.2. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
7.4.2.1. Asia Pacific Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
7.4.2.2. Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
7.4.2.3. Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
7.4.3. Asia Pacific Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
7.4.4. Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.5. Latin America Dermatology Diagnostic Devices and Therapeutics Market
7.5.1. Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
7.5.2. Latin America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
7.5.2.1. Latin America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
7.5.2.2. Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
7.5.2.3. Latin America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
7.5.3. Latin America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
7.5.4. Latin America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.6. Middle East and North Africa (MENA) Dermatology Diagnostic Devices and Therapeutics Market
7.6.1. MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
7.6.2. MENA Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
7.6.2.1. MENA Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
7.6.2.2. MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
7.6.2.3. MENA Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
7.6.3. MENA Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
7.6.4. MENA Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.7. Rest of the World (ROW) Dermatology Diagnostic Devices and Therapeutics Market
7.7.1. ROW Dermatology Diagnostic Devices Market Revenue, 2014–2024 (US$ Mn)
7.7.2. ROW Dermatology Therapeutics Market Revenue, 2014–2024 (US$ Mn)

Section-8 Historical Snapshot and Current Trends

Section-9 Company Profiles
9.1 Agfa-Gevaert N.V.
9.1.1 Company Overview (HQ, Business Segments, Employee Strength)
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Strategic Overview
9.2 Astellas Pharma, Inc.
9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2. Financial Overview
9.2.3. Product Portfolio
9.2.4. Strategic Overview
9.3 Cutera, Inc.
9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.3.2. Financial Overview
9.3.3. Product Portfolio
9.3.4. Strategic Overview
9.4 Dino-Lite Europe/IDCP BV.
9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.4.2. Product Portfolio
9.4.3. Strategic Overview
9.5 Galderma S.A.
9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.5.2. Financial Overview
9.5.3. Product Portfolio
9.5.5. Strategic Overview
9.6 Genentech, a Roche Company
9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.6.2. Product Portfolio
9.6.3. Strategic Overview
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.7.2. Financial Overview
9.7.3. Product Portfolio
9.7.4. Strategic Overview
9.8 LEO Pharma A/S
9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.8.2. Financial Overview
9.8.3. Product Portfolio
9.8.4. Strategic Overview
9.9 Michelson Diagnostics Ltd.
9.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.9.2. Product Portfolio
9.9.3. Strategic Overview
9.10 Novartis International AG
9.10.1. Company Overview (HQ, Business Segments, Employee Strength)
9.10.2. Financial Overview
9.10.3. Product Portfolio
9.10.4. Strategic Overview
9.11 Valeant Pharmaceuticals International, Inc.
9.11.1. Company Overview (HQ, Business Segments, Employee Strength)
9.11.2. Financial Overview
9.11.3. Product Portfolio
9.11.4. Strategic Overview
9.12 Canfield Scientific, Inc.
9.12.1. Company Overview (HQ, Business Segments, Employee Strength)
9.12.2. Product Portfolio
9.12.3. Strategic Overview

List of Tables

Table 01 : Global Dermatology Diagnostic Devices Market, by Product, (US$ Mn), 2014–2024
Table 02 : Global Dermatoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 03 : Global Microscopes and Trichoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 04 : Global Imaging Equipment Market Revenue, by Product, (US$ Mn) , 2014–2024
Table 05 : Global Dermatology Therapeutics Market, by Drug Class, (US$ Mn), 2014–2024
Table 06 : Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)
Table 07 : Global Dermatology Diagnostic Devices Market Revenue, by Region, (US$ Mn), 2014–2024
Table 08 : Global Dermatology Therapeutics Market Revenue, by Region, (US$ Mn), 2014–2024
Table 09 : North America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 10 : North America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 11 : North America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 12 : North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 13 : North America Dermatology Imaging Equipment Market Revenue, by Product Type, 2014–2024 (US$ Mn)
Table 14 : North America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 15 : North America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 16 : Europe Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 17 : Europe Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 18 : Europe Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 19 : Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 20 : Europe Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 21 : Europe Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 22 : Europe Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 23 : APAC Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 24 : Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 25 : Asia Pacific Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 26 : Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 27 : Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 28 : Asia Pacific Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 29 : Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 30 : Latin America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 31 : Latin America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 32 : Latin America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 33 : Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 34 : Latin America Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 35 : Latin America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 36 : Latin America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 37 : MENA Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 38 : MENA Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 39 : MENA Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 40 : MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 41 : MENA Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 42 : MENA Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 43 : MENA Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024